Botulism in Canada.
Weir
E
E
D000992:Antitoxins / Q000627:therapeutic use; D001906:Botulism / Q000145:classification / Q000453:epidemiology* / Q000628:therapy* / Q000635:transmission; D002170:Canada / Q000453:epidemiology; D003014:Clostridium botulinum; D006801:Humans; D009498:Neurotoxins; D011159:Population Surveillance; D011322:Primary Prevention / Q000379:methods; D015980:Public Health Practice
D000992:Antitoxins; D009498:Neurotoxins